Early autologous stem cell transplantation for poor-risk Chronic Lymphocytic Leukemia (CLL): prognostic factors for feasibility and molecular outcome

被引：0
|
作者：
Dreger, P
von Neuhoff, N
Wittkowsky, G
Sonnen, R
Seyfarth, B
Kuse, R
Glass, B
Schmitz, N
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S36 / S37
页数：2
相关论文
共 50 条
  • [21] Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia
    Dreger, P
    Montserrat, E
    LEUKEMIA, 2002, 16 (06) : 985 - 992
  • [22] Quality of life (QoL) assessment in patients allografted for poor-risk chronic lymphocytic leukemia (CLL)
    Hahn, M.
    Dietrich, S.
    Hegenbart, U.
    Bondong, A.
    Ho, A. D.
    Dreger, P.
    Oncology Research and Treatment, 2015, 38 : 141 - 141
  • [23] Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia
    P Dreger
    E Montserrat
    Leukemia, 2002, 16 : 985 - 992
  • [24] Hematopoietic stem cell transplantation (SCT) for chronic lymphocytic leukemia (CLL).
    Horowitz, MM
    Montserrat, E
    Sobocinski, K
    Giralt, S
    Khouri, IF
    Schmitz, N
    BLOOD, 2000, 96 (11) : 522A - 522A
  • [25] Impact of telomere length on the outcome of allogeneic stem cell transplantation for poor-risk chronic lymphocytic leukaemia: results from the GCLLSG CLL3X trial
    Scheffold, Annika
    Jebaraj, Billy Michael Chelliah
    Jaramillo, Sonia
    Tausch, Eugen
    Steinbrecher, Daniela
    Hahn, Michael
    Boettcher, Sebastian
    Ritgen, Matthias
    Bunjes, Donald
    Zeis, Matthias
    Stadler, Michael
    Uharek, Lutz
    Scheid, Christoph
    Hegenbart, Ute
    Hallek, Michael
    Kneba, Michael
    Schmitz, Norbert
    Doehner, Hartmut
    Dreger, Peter
    Stilgenbauer, Stephan
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 179 (02) : 342 - 346
  • [26] Rituxan in vivo purging of stem cells for autologous transplantation in chronic lymphocytic leukemia (CLL).
    Berkahn, LC
    Simpson, DR
    Raptis, A
    Pavletic, S
    Klingemann, HG
    BLOOD, 2000, 96 (11) : 186A - 186A
  • [27] CD38 expression has no prognostic influence after autologous stem cell transplantation (SCT) for chronic lymphocytic leukemia (CLL)
    Schloe, U
    Viehmann, K
    Lange, A
    Ritgen, M
    Dreger, P
    BONE MARROW TRANSPLANTATION, 2002, 29 : S165 - S165
  • [28] Autologous bone marrow transplantation in chronic lymphocytic leukemia (CLL)
    Mangoni, L
    Rizzoli, V
    BIOMEDICINE & PHARMACOTHERAPY, 1996, 50 (09) : 442 - 446
  • [29] Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcome
    Steinbrecher, Daniela
    Jebaraj, Billy Michael Chelliah
    Schneider, Christof
    Edelmann, Jennifer
    Cymbalista, Florence
    Leblond, Veronique
    Delmer, Alain
    Ibach, Stefan
    Tausch, Eugen
    Scheffold, Annika
    Bloehdorn, Johannes
    Hallek, Michael
    Dreger, Peter
    Doehner, Hartmut
    Stilgenbauer, Stephan
    LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1614 - 1623
  • [30] Long-term disease control of poor-risk chronic lymphocytic leukemia (CLL) by allogeneic stem cell transplantation with nonmyeloablative conditioning (NST):: Interim results of a prospective study
    Dreger, P
    Stilgenbauer, S
    Boettcher, S
    Bunjes, D
    Ottinger, H
    Beelen, D
    Cohen, S
    Schubert, J
    Hertenstein, B
    Basara, N
    Humpe, A
    Ritgen, M
    Zeis, M
    Schmitz, N
    Hallek, M
    Kneba, M
    Döhner, H
    ANNALS OF ONCOLOGY, 2005, 16 : 43 - 44
12345